Lv3
322 积分 2025-08-22 加入
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
14天前
已完结
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)
15天前
已完结
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
16天前
已完结
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
16天前
已完结
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)
21天前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
1个月前
已完结
Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer
1个月前
已完结
ATOMIC Energy — Biomarker-Bespoke Adjuvant Therapy for Colon Cancer
1个月前
已完结
Pathological-Features-Modified TNM Staging System Improves Prognostic Accuracy for Rectal Cancer
1个月前
已完结
Prospective evaluation of radical surgery for adenocarcinoma of oesophagogastric junction: real-world insights from the CLAEG study
1个月前
已完结
皖公网安备34019202002308
